MYC Is Activated by USP2a-Mediated Modulation of MicroRNAs in Prostate Cancer
Barbara Benassi(National Agency for New Technologies, Energy and Sustainable Economic Development), Massimo Loda(Brigham and Women's Hospital)
Cited by 103
Related Papers
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
|Proceedings of the National Academy of Sciences|2018|288
Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis
|American Journal Of Pathology|2010|184
Establishment and Genomic Characterization of Mouse Xenografts of Human Primary Prostate Tumors
|American Journal Of Pathology|2010|63
USP2a alters chemotherapeutic response by modulating redox
|Cell Death and Disease|2013|37